Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Does Regional Anaesthesia Increase Peripheral Nerve Injury After Blast Trauma? A Randomized Trial

NCT07879508 is registered in ClinicalTrials.gov with Ukrainian Society of Regional Anesthesia and Pain Therapy as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07879508 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Does Regional Anaesthesia Increase Peripheral Nerve Injury After Blast Trauma? A Randomized Trial
Lead sponsor
Ukrainian Society of Regional Anesthesia and Pain Therapy
Phase
Not applicable
Overall status
Not yet recruiting
Start date
December 23, 2026
Completion date
November 23, 2027
Enrollment
150 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

blast injury, combat related symptoms, combat trauma, nerve block, nerve blocks, nerve injury

Arms

As registered; 2 arms.

  • Standardized Multimodal Systemic Analgesia Active comparatorStandardized Multimodal Analgesia

    Participants receive standardized multimodal systemic analgesia without a planned peripheral nerve block. A rescue nerve block is permitted when clinically necessary and will be recorded.

  • Ultrasound-Guided Regional Anaesthesia ExperimentalUltrasound-Guided Regional Anaesthesia

    Participants receive an ultrasound-guided peripheral nerve block plus standardized multimodal analgesia.

Primary endpoints

Registered primary outcome measures; 1 primary.

  • New or Worsened Peripheral Nerve Deficit at 30 Days 30 days after randomization

    Peripheral nerve function will be assessed before randomization and at 30 days using a standardized bilateral neurological examination. Motor function will be graded with the Medical Research Council (MRC) scale (0-5) in muscle groups corresponding to the injured limb and relevant peripheral nerves. Sensory function will be mapped in predefined nerve territories using light touch and pinprick and graded as 0 = absent, 1 = reduced/abnormal, or 2 = normal. New neuropathic symptoms, including numbness, tingling, burning pain, or allodynia, will also be documented.

    A primary outcome event is defined as a new sensory or motor deficit, or worsening of a pre-existing deficit, compared with the pre-randomization examination. Persistent, severe, progressive, or anatomically unexplained deficits will undergo neurological consultation and, when clinically indicated, nerve conduction studies/electromyography and/or ultrasound or MRI. Final outcome classification will be made by independent assess

Lead sponsor's other trials

Ukrainian Society of Regional Anesthesia and Pain Therapy, most recent start first.

Similar trials

Same condition (Blast Injuries) and phase, most recent start first.